In colon cancer, COX-2 overexpression in TAMs can also upregulate TGF-β through a paracrine pathway, activating TGF-β-induced signaling pathways independent of Smads, such as the NF-kappaB (NF-κB) pathway. Here, TGFB1 is linked to colonic neoplasm.